Literature DB >> 21938261

Statins for prevention of diabetic-related blindness: a new treatment option?

Mona F El-Azab1, Barbara A Mysona, Azza B El-Remessy.   

Abstract

Entities:  

Year:  2011        PMID： 21938261      PMCID： PMC3175606          DOI： 10.1586/eop.11.36

Source DB:  PubMed          Journal:  Expert Rev Ophthalmol        ISSN： 1746-9899


× No keyword cloud information.
  35 in total

Review 1.  Pleiotropic effects of statins. - Basic research and clinical perspectives -.

Authors:  Qian Zhou; James K Liao
Journal:  Circ J       Date:  2010-04-15       Impact factor: 2.993

2.  HMG-CoA reductase inhibitors induce apoptosis in pericytes.

Authors:  Kelly Boucher; Chad S Siegel; Parul Sharma; Peter V Hauschka; Keith R Solomon
Journal:  Microvasc Res       Date:  2006-01-19       Impact factor: 3.514

3.  Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment.

Authors:  Toru Nakazawa; Hidetoshi Takahashi; Kazuaki Nishijima; Masahiko Shimura; Nobuo Fuse; Makoto Tamai; Ali Hafezi-Moghadam; Kohji Nishida
Journal:  J Neurochem       Date:  2007-02       Impact factor: 5.372

Review 4.  Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

Authors:  Ruth B Caldwell; Manuela Bartoli; M Ali Behzadian; Azza E B El-Remessy; Mohamed Al-Shabrawey; Daniel H Platt; Gregory I Liou; R William Caldwell
Journal:  Curr Drug Targets       Date:  2005-06       Impact factor: 3.465

Review 5.  Diabetic retinopathy: current management and experimental therapeutic targets.

Authors:  Tayyeba K Ali; Azza B El-Remessy
Journal:  Pharmacotherapy       Date:  2009-02       Impact factor: 4.705

6.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

7.  Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.

Authors:  Shinsuke Miyahara; Junichi Kiryu; Kenji Yamashiro; Kazuaki Miyamoto; Fumitaka Hirose; Hiroshi Tamura; Hideto Katsuta; Kazuaki Nishijima; Akitaka Tsujikawa; Yoshihito Honda
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

8.  Pitavastatin: protection against neuronal retinal damage induced by ischemia-reperfusion injury in rats.

Authors:  Takahiro Kawaji; Yasuya Inomata; Akiomi Takano; Nina Sagara; Masaru Inatani; Mikiko Fukushima; Hidenobu Tanihara; Megumi Honjo
Journal:  Curr Eye Res       Date:  2007-11       Impact factor: 2.424

9.  Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion.

Authors:  Carin Gustavsson; Carl-David Agardh; Per Hagert; Elisabet Agardh
Journal:  Retina       Date:  2008-04       Impact factor: 4.256

10.  Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.

Authors:  Jingming Li; Joshua J Wang; Danyang Chen; Robert Mott; Qiang Yu; Jian-xing Ma; Sarah X Zhang
Journal:  Exp Eye Res       Date:  2009-02-28       Impact factor: 3.467
View more
  1 in total

1.  Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).

Authors:  Monika Yadav; Nicola Schiavone; Ana Guzman-Aranguez; Fabrizio Giansanti; Laura Papucci; Maria J Perez de Lara; Mandeep Singh; Indu Pal Kaur
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 4.617
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.